erentiated” neuroendocrine cancer, that is, neuroendocrine y targets rapidly dividing cells and so may be able to gain quicker shrinkage. If your cancer does not respond well to the first choice of e difficult to tolerate or manage, an alternative drug or combination once chemotherapy stops. ng treatment - and is maintained after treatment stops (for at least 3 sidered. ted or another chemotherapy or combination may be discussed with
ed in some lung and pancreatic neuroendocrine tumours (NETs).
TARGETED MOLECULAR MEDICAL THERAPIES (TMMTs) TMMTs, for neuroendocrine cancer, can be given orally (in tablets) or intravenously (through a vein) to slow tumour growth or try to reduce tumour size. TMMTs are drugs or other substances that work against cancer by interfering with specific molecules that are involved in the growth, progression, and spread of cancer. Many different targeted therapies have been approved for use in cancer treatment. These therapies include hormone therapies, signal transduction inhibitors, gene expression modulators, apoptosis inducers, angiogenesis inhibitors, immunotherapies, and toxin delivery molecules.
Made with FlippingBook - Share PDF online